Data / Drug companies / Colesevelam hydrochloride
Colesevelam hydrochloride: 12 companies and 21 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Colesevelam hydrochloride is listed in the FDA National Drug Code Directory by 12 companies, with 21 products in commercial distribution. 19 of the products (90.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; powder, for suspension, and the newest product started marketing on September 30, 2026.
The request: Get every company that lists colesevelam hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 21
- Generic (ANDA) products
- 19 (90.5%)
- Application numbers
- 10
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list colesevelam hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | August 1, 2022 |
| Bionpharma Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | September 30, 2026 |
| Amneal Pharmaceuticals of New York LLC | 2 | for suspension; tablet, film coated | Generic drugs (ANDA) | January 20, 2023 |
| Glenmark Pharmaceuticals Inc., USA | 2 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | July 16, 2018 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | August 9, 2018 |
| Ascend Laboratories, LLC | 1 | powder, for suspension | Generic drugs (ANDA) | May 9, 2019 |
| Bryant Ranch Prepack | 1 | powder, for suspension | Generic drugs (ANDA) | May 9, 2019 |
| Bryant Ranch Prepack | 1 | powder, for suspension | Generic drugs (ANDA) | May 9, 2019 |
| Cranbury Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | October 19, 2020 |
| Dr. Reddy's Laboratories Inc. | 1 | tablet | Generic drugs (ANDA) | October 5, 2018 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | July 15, 2020 |
| Macleods Pharmaceuticals Limited | 1 | tablet, film coated | Generic drugs (ANDA) | April 18, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 10 | 47.6% |
| Tablet | 6 | 28.6% |
| Powder, for suspension | 4 | 19% |
| For suspension | 1 | 4.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 19 | 90.5% |
| New drug applications (NDA) | 2 | 9.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Bile Acid Sequestrant | 21 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.